Related Experiment Video
Updated: Jan 20, 2026

Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
Published on: July 29, 2021
Characterization of in vitro Mrp2 transporter model based on intestinal organoids
Lei Zhang1, Chenmeizi Liang2, Peipei Xu2
1East China Normal University and Shanghai Fengxian District Central Hospital Joint Research Center for Translational Medicine, Shanghai Key laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; Department of Pharmacy, Shanghai Fengxian District Central Hospital, Shanghai, China.
Abstract:
Multidrug resistance associated protein 2 (MRP2) is an important efflux transporter involved in clinical drug disposition and drug-drug interactions. The study of MRP2-mediated drug transport has become an integral part of drug discovery and development. In particular, screening of specific MRP2 inhibitors will help overcome the multidrug resistance in cancer. In this report, a new method for rapid and sensitive detection of Mrp2 function was established via using mouse small intestinal organoids. Firstly, small intestinal crypts isolated from mouse intestine were induced by Noggin, R-spondin1 and EGF to develop three-dimensional (3D) organoids. Secondly, the 3D organoids were characterized by the physical and physiological structure of Mrp2-mediated drug transport. Finally, Mrp2 fluorescent substrate 5(6)-carboxyl- 2', 7'-dichlorofluorescein (CDF) and its inhibitor MK-571 and probenecid were used to demonstrate Mrp2-mediated CDF transport in 3D organoids. The results showed that the small intestinal organoids have a physiological structure for Mrp2-mediated compound transport. Moreover, MK-571 and probenecid, inhibitors of MRP2, significantly decreased the accumulation of CDF in 3D organoids. In summary, a novel intestinal organoid model has been successfully established for the rapid and effective study of Mrp2-mediated drug transport.
Insights
A novel mouse intestinal organoid model effectively detects Multidrug resistance associated protein 2 (MRP2) function. This method aids in screening MRP2 inhibitors to combat multidrug resistance in cancer therapy.
Area of Science:
- Pharmacology
- Drug Discovery
- Molecular Biology
Background:
- Multidrug resistance associated protein 2 (MRP2) is crucial for drug disposition and interactions.
- Understanding MRP2 function is vital for drug discovery and overcoming cancer multidrug resistance.
Purpose of the Study:
- To establish a rapid and sensitive method for detecting MRP2 function using mouse intestinal organoids.
- To validate the utility of this model for studying MRP2-mediated drug transport.
Main Methods:
- Mouse intestinal crypts were cultured to form 3D organoids.
- Organoids were characterized for their physiological structure relevant to MRP2 transport.
- MRP2-mediated transport of a fluorescent substrate (CDF) was assessed using inhibitors (MK-571, probenecid).
Main Results:
- The 3D intestinal organoids exhibited a suitable physiological structure for MRP2-mediated transport.
- Inhibitors MK-571 and probenecid significantly reduced CDF accumulation, confirming MRP2 activity.
- The model demonstrated rapid and effective detection of MRP2-mediated drug transport.
Conclusions:
- A novel intestinal organoid model was successfully developed for studying MRP2 function.
- This model provides a valuable tool for screening MRP2 inhibitors and understanding drug transport.
- The findings support the use of organoids in drug discovery and overcoming multidrug resistance.
More Related Videos
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Facilitated Transport
Regulated mRNA Transport
Primary Active Transport
Secondary Active Transport
Phloem and Sugar Transport

